TCR2 Therapeutics
Non-Profit & Charitable Organizations · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
100 Binney St, Cambridge, Massachusetts,...Phone Number
(617) 949-5200Website
www.tcr2.comRevenue
$29 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
3
1
1
1
1
About TCR2 Therapeutics
At TCR, we are very active in giving back to our local and patient communities. TCR Cares is an employee-initiated program established in 2015 that focuses on giving back to our community in ways that connect to our corporate goal of curing cancer. As a result, we tend to support cancer-related charities and those involved in educating children about science, especially those from underserved communities. Check out some of our recent projects:Explore more
TCR2 Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is TCR2 Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if TCR2 Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once TCR2 Therapeutics has new funding data
TCR2 Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at TCR2 Therapeutics
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on TCR2 Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when TCR2 Therapeutics launches new products
Check if TCR2 Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if TCR2 Therapeutics is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to TCR2 Therapeutics
Compare insights from companies similar to TCR2 Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
TCR2 Therapeutics is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
TCR2 Therapeutics is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about TCR2 Therapeutics.
TCR2 Therapeutics Tech Stack
A closer look at the technologies used by TCR2 Therapeutics
Most Recent Scoops
Left Company
Executive Move
Left Company
Executive Move
New Hire
Executive Move
Left Company
Executive Move
Left Company
Executive Move
TCR2 Therapeutics News & Media
Will Tango Therapeutics (NASDAQ:TNGX) Spend Its Cash Wisely?
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...Tango Therapeutics to Participate in Upcoming Investor Conferences
BOSTON, June 01, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that members of the management team are scheduled to participate in the following upcoming investor conferences in June.TCR² Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR) (TCR2 or the Company), a clinical-stage cell therapy company with a pipeline of novel next-generation T cell therapies for patients suffering from solid tumors, today announced financial results for the first quarter ended March 31, 2023 and provided a corporate update.Tango Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Highlights
– Dose escalation update from ongoing TNG908 clinical trial confirms proof-of-mechanism for MTA-cooperative tumor-selective PRMT5 inhibition in MTAP-deleted cancers –
Read more news
Top Non-Profit & Charitable Organizations Companies
Frequently Asked Questions Regarding TCR2 Therapeutics
Sign Up For FreeTo access detailed company insights
At TCR, we are very active in giving back to our local and patient communities. TCR Cares is an employee-initiated program established in 2015 that focuses on giving back to our community in ways that connect to our corporate goal of curing cancer. As a result, we tend to support cancer-related charities and those involved in educating children abo... Read More
